Press Releases

CHICAGO, Ill. — Roswell Park Comprehensive Cancer Center researchers have identified a potential key player promoting cancer progression through changes in the cell environment that are conducive to metastasis.

CHICAGO, Ill. — Roswell Park Comprehensive Cancer Center researchers have identified the histone H2AX as a potential biomarker for breast cancer — a determination that could also help predict how a patient will respond to radiation therapy.

Blood and marrow transplant, or BMT, is a lifesaving and effective treatment for many patients, but the procedure can cause serious and life-threatening complications. New research out of Roswell Park Comprehensive Cancer Center and The Ohio State University has identified a link between rare variants in a number of novel genes and survival after transplantation of blood and marrow from an unrelated donor, opening avenues for improving individual risk prediction and prognosis for patients undergoing BMT.

Looking to identify new strategies to prevent breast cancer recurrence, a research team led by Subhamoy Dasgupta, PhD, Assistant Professor of Oncology in the Department of Cell Stress Biology at Roswell Park Comprehensive Cancer Center, has identified two key proteins involved in glucose metabolism that could be targeted to prevent breast cancer metastasis and recurrence. The team’s findings were published today in the journal Nature.

BUFFALO, N.Y. — A scientist with more than 20 years of experience has been appointed as the new Chair of Molecular and Cellular Biology at Roswell Park Comprehensive Cancer Center. Erik Knudsen, PhD, will also serve as the Co-Leader of the Cancer Center’s Genetics and Genomics Program.